← Back to Search

light-scattering spectroscopy for Breast Cancer

N/A

Waitlist Available

Research Sponsored by Vanderbilt University

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up 2 years

Awards & highlights

Study Summary

This trial is using optical spectroscopy to see how well it works in evaluating tumor margins in patients who have undergone surgery for breast cancer.

Eligible Conditions

Breast Cancer

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ 2 years

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~2 years

This trial's timeline: 3 weeks for screening, Varies for treatment, and 2 years for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Development of a non-invasive detection tool that evaluates breast tumor margins in real-time to guide tumor resection during partial mastectomy procedures

Evaluated optical spectroscopy in differentiating breast tumor or tumor margins from normal breast tissue

Trial Design

1Treatment groups

Experimental Treatment

Group I: Optical spectroscopy on tumor marginsExperimental Treatment4 Interventions

Optical spectroscopy is performed on breast tumor margins obtained from patients undergoing surgery

Treatment

First Studied

Drug Approval Stage

How many patients have taken this drug

breast biopsy

2006

N/A

~110

light-scattering spectroscopy

2006

N/A

~110

therapeutic conventional surgery

2003

Completed Phase 3

~12270

histopathologic examination

2003

Completed Phase 2

~170

Do I qualify?Apply below to find out

Find a Location

Who is running the clinical trial?

Vanderbilt UniversityLead Sponsor

703 Previous Clinical Trials

6,143,245 Total Patients Enrolled

11 Trials studying Breast Cancer

1,430 Patients Enrolled for Breast Cancer

National Cancer Institute (NCI)NIH

13,658 Previous Clinical Trials

40,924,387 Total Patients Enrolled

939 Trials studying Breast Cancer

1,543,258 Patients Enrolled for Breast Cancer

Anita Mahadevan-Jansen, MDStudy Chair - Vanderbilt-Ingram Cancer Center

Vanderbilt University

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

To what extent has this research been embraced by participants?

"Valid. According to clinicaltrials.gov, the trial commenced on August 1st 2006 and is actively recruiting for 180 participants from three distinct healthcare facilities as of December 6th 2021."

Answered by AI

Are participants being recruited for this experiment currently?

"Affirmative. Per the clinicaltrials.gov database, this research initiative is open to new participants and has been since August 1st 2006 (last updated December 6th 2021). A total of 180 patients are being sought at 3 medical centres."

Answered by AI

Is this research open to individuals in the geriatric age range?

"Patients aged 18 to 99 may enroll in this trial. There are 74 trials for minors and 2508 for seniors."

Answered by AI

Who is eligible to partake in this research experiment?

"Eligibility criteria for this study includes a diagnosis of breast cancer and an age between 18-99 years old. 180 total participants will be enrolled in the trial."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

Optical Spectroscopy in Evaluating Tumor Margins in Patients Who Have Undergone Surgery for Breast Tumors

Anita Mahadevan-Jansen 2006. "Optical Spectroscopy in Evaluating Tumor Margins in Patients Who Have Undergone Surgery for Breast Tumors". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT00625417.